Dysregulation of the mTOR pathway secondary to mutations or a hostile microenvironment contributes to cancer and poor wound healing

Journal of Investigative Dermatology

Volumn 129, Issue 3, 2009, Pages 529-531

  Clark, Richard A F ^a   Pavlis, Michelle ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; VASCULOTROPIN;

CANCER GROWTH; COWDEN SYNDROME; DISEASE ASSOCIATION; EPIDERMIS CELL; HUMAN; MICROENVIRONMENT; MULTIPLE CANCER; NEOPLASM; NOTE; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; TUBEROUS SCLEROSIS; WOUND HEALING;

EID: 59949099341     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.441     Document Type: Note

References (19)

1. Amos C, Keitheri-Cheteri M, Sabripour M, Wei C, McGarrity T, Seldin M et al. (2004) Genotype-phenotype correlations in Peutz-Jeghers syndrome. J Med Genet 41:327-33
2. Bauer AJ, Stratakis CA (2005) The lentiginoses: cutaneous markers of systemic disease and a window to new aspects of tumourigenesis. J Med Genet 42:801-10
3. Calautti E, Li J, Saoncella S, Brissette JL, Goetinck PF (2005) Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death. J Biol Chem 280:32856-65
4. Chow LM, Baker SJ (2006) PTEN function in normal and neoplastic growth. Cancer Lett 241:184-96
5. Goren I, Müller E, Schiefelbein D, Gutwein P, Seitz O, Pfeilschifter J et al. (2009) Akt1 controls insulin-driven VEGF biosynthesis from keratinocytes: implications for normal and diabetes-impaired skin repair in mice. J Invest Dermatol 129:752-64
6. Grant S (2008) Cotargeting survival signaling pathways in cancer. J Clin Invest 118:3003-6
7. Happle R (2007) Type 2 segmental Cowden disease vs. Proteus syndrome. Br J Dermatol 156:1089-90
8. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18:1926-45
9. Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF et al. (1999) PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet 8:1461-72
10. Murayama K, Kimura T, Tarutani M, Tomooka M, Hayashi R, Okabe M et al. (2007) Akt activation induces epidermal hyperplasia and proliferation of epidermal progenitors. Oncogene 26:4882-8
11. Nobukuni T, Joaquin M, Roccio M, Dann SG, Kim SY, Gulati P et al. (2005) Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci USA 102:14238-43
12. Pankow S, Bamberger C, Klippel A, Werner S (2006) Regulation of epidermal homeostasis and repair by phosphoinositide 3-kinase. J Cell Sci 119:4033-46
13. Pilarski R, Eng C (2004) Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 41:323-6
14. Sabatini DM (2006) mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 6:729-34
15. Schwartz RA, Fernandez G, Kotulska K, Jozwiak S (2007) Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol 57:189-202
16. Shaw RJ, Cantley LC (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441:424-30
17. Smith JM, Kirk EP, Theodosopoulos G, Marshall GM, Walker J, Rogers M et al. (2002) Germline mutation of the tumour suppressor PTEN in Proteus syndrome. J Med Genet 39:937-40
18. Wouters BG, Koritzinsky M (2008) Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 8:851-64
19. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124:471-84